Loading…
MPM Medical acquired a full collagen manufacturing platform and FDA 510(k) clearance for surgical collagen devices, and will operate production from its 100,000-square-foot FDA-registered facility in Mesquite, Texas starting January 1, 2026.
“By bringing surgical and wound care collagen manufacturing fully in-house, we can innovate faster, scale production responsibly, and provide our partners with reliable, FDA-cleared solutions.”medicaldesigndevelopment.com
Summarized from public sources; check the original articles before acting on it.